Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep874 | Thyroid cancer | ECE2015

Differentiated thyroid cancer: tendency changes from 1970 to 2012 in the southwest of Spain

Ortega Antonio Jesus Martinez , Gonzalez Elena Navarro , Vazquez Raquel Guerrero , de los Reyes Romero Lluch Ana , Martos Jose Manuel , Cuenca Ignacio Cuenca

There is a specific unit specialised in treating differentiated thyroid cancer (DTC) at the Endocrinology Department from a hospital the southwest of Spain that attends patients from two different provinces. Owing to environmental pollution, one of them has higher incidence of cancer.To evaluate the changes in the clinical presentation of DTC over time and analyse possible differences between patients from the two provinces, we designed a descriptive ret...

ea0056gp228 | Thyroid Cancer - Diagnostics & Treatments | ECE2018

Familial non-medullary thyroid carcinoma. Are we facing a different entity?

Remon-Ruiz Pablo , Romero-Lluch Ana , Duenas-Disotuar Suset , Cuenca Ignacio , Martos-Martinez Juan , Navarro Elena

Background: Familial non medullary thyroid carcinoma (FNMTC) is a not very well known histopatologic entity. Nowadays there are controversial publications about his aggresiveness and prognosisObjective: To know the clinical outcomes and histopathological characteristics of our patients with FNMTC and to compare them with a cohort of patients with sporadic non medullary thyroid carcinoma (CDT).Methods: We conducted a retrospective d...

ea0073pep9.8 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

Romero LLuch Ana R. , Disotuar Suset Dueñas , Tous Romero Marai C. , Fernández Peña J. Ignacio , Cuenca Cuenca J. Ignacio , Elena Navarro

IntroductionBased on the evidence available back then, in 2015 we developed a provincial multicenter protocol for screening and follow up of no-index patients with SDHB and SDHC mutations.Objectives1. To evaluate the performance of the protocol designed for the follow-up of asymptomatic SDHB and C carriers. 2. To describe the penetrance of manifestations associated with hereditary PGL-FEO syndromes type 3 and...